These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34599770)

  • 1. Physical Disruption of Solid Tumors by Immunostimulatory Microrobots Enhances Antitumor Immunity.
    Zhou J; Karshalev E; Mundaca-Uribe R; Esteban-Fernández de Ávila B; Krishnan N; Xiao C; Ventura CJ; Gong H; Zhang Q; Gao W; Fang RH; Wang J; Zhang L
    Adv Mater; 2021 Dec; 33(49):e2103505. PubMed ID: 34599770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
    Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetically Powered Immunogenic Macrophage Microrobots for Targeted Multimodal Cancer Therapy.
    Li Y; Cong Z; Xie L; Tang S; Ren C; Peng X; Tang D; Wan F; Han H; Zhang X; Gao W; Wu S
    Small; 2023 Oct; 19(42):e2301489. PubMed ID: 37300342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ vaccination: Harvesting low hanging fruit on the cancer immunotherapy tree.
    Sheen MR; Fiering S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jan; 11(1):e1524. PubMed ID: 29667346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-Immune-Engineering Approaches to Advance Cancer Immunotherapy: Lessons from Ultra-pH-Sensitive Nanoparticles.
    Li S; Bennett ZT; Sumer BD; Gao J
    Acc Chem Res; 2020 Nov; 53(11):2546-2557. PubMed ID: 33063517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using nanoparticles for
    Gorbet MJ; Singh A; Mao C; Fiering S; Ranjan A
    Int J Hyperthermia; 2020 Dec; 37(3):18-33. PubMed ID: 33426995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.
    Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral immunotherapy: using the tumor as the remedy.
    Marabelle A; Tselikas L; de Baere T; Houot R
    Ann Oncol; 2017 Dec; 28(suppl_12):xii33-xii43. PubMed ID: 29253115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci.
    Kanwar JR; Kanwar RK; Pandey S; Ching LM; Krissansen GW
    Cancer Res; 2001 Mar; 61(5):1948-56. PubMed ID: 11280751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics.
    Buss CG; Bhatia SN
    Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13428-13436. PubMed ID: 32493746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity.
    Wang G; Chow RD; Bai Z; Zhu L; Errami Y; Dai X; Dong MB; Ye L; Zhang X; Renauer PA; Park JJ; Shen L; Ye H; Fuchs CS; Chen S
    Nat Immunol; 2019 Nov; 20(11):1494-1505. PubMed ID: 31611701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytochemical Engineered Bacterial Outer Membrane Vesicles for Photodynamic Effects Promoted Immunotherapy.
    Zhuang WR; Wang Y; Lei Y; Zuo L; Jiang A; Wu G; Nie W; Huang LL; Xie HY
    Nano Lett; 2022 Jun; 22(11):4491-4500. PubMed ID: 35605283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulating antitumor immunity with nanoparticles.
    Sheen MR; Lizotte PH; Toraya-Brown S; Fiering S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(5):496-505. PubMed ID: 25069691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity.
    Anfray C; Mainini F; Digifico E; Maeda A; Sironi M; Erreni M; Anselmo A; Ummarino A; Gandoy S; Expósito F; Redrado M; Serrano D; Calvo A; Martens M; Bravo S; Mantovani A; Allavena P; Andón FT
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34531246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ vaccination with biocompatibility controllable immuno-sensitizer inducing antitumor immunity.
    Shin H; Na K
    Biomaterials; 2019 Mar; 197():32-40. PubMed ID: 30639548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional Biomimetic Nanovaccines Based on Photothermal and Weak-Immunostimulatory Nanoparticulate Cores for the Immunotherapy of Solid Tumors.
    Li J; Huang D; Cheng R; Figueiredo P; Fontana F; Correia A; Wang S; Liu Z; Kemell M; Torrieri G; Mäkilä EM; Salonen JJ; Hirvonen J; Gao Y; Li J; Luo Z; Santos HA; Xia B
    Adv Mater; 2022 Mar; 34(9):e2108012. PubMed ID: 34877724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage-Based Microrobots for Anticancer Therapy: Recent Progress and Future Perspectives.
    Nguyen VD; Park JO; Choi E
    Biomimetics (Basel); 2023 Nov; 8(7):. PubMed ID: 37999194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral Immunotherapy: From Trial Design to Clinical Practice.
    Champiat S; Tselikas L; Farhane S; Raoult T; Texier M; Lanoy E; Massard C; Robert C; Ammari S; De Baère T; Marabelle A
    Clin Cancer Res; 2021 Feb; 27(3):665-679. PubMed ID: 32943460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.